CONTACT

Request for information.

Whether you're a researcher, clinician, prospective partner, or investor — we're glad to hear from you. Reach out and we'll route your inquiry to the right team.

Cell Technologies laboratory
GENERAL ENQUIRIES

Get in touch.

For all inquiries — clinical, scientific, partnership, regulatory, or media — please email us. We respond to qualified inquiries within two business days.

info@celltechnologies.net
INVESTORS
info@celltechnologies.net  (subject: Investor Inquiry)
PARTNERSHIPS
info@celltechnologies.net  (subject: Partnership Inquiry)
MEDIA
info@celltechnologies.net  (subject: Media Inquiry)
JOIN OUR MAILING LIST

Stay informed.

Sign up with your email address to receive news on clinical progress, platform updates, and company milestones.

Thank you — we'll be in touch.
Cell Technologies

A clinical-stage AI-native pharmaceutical company advancing FDA and Health Canada-approved stem cell technology to market, powered by Oracle and Delfi — proprietary platforms purpose-built for the decisions that determine whether new medicines reach patients.

Company
  • About
  • Our Technology
  • Pipeline
  • Investors
  • Contact
Contact
  • info@celltechnologies.net
  • celltechnologies.net
© 2026 Cell Technologies, Inc. Powered by Oracle + Delfi — Proprietary AI Platforms
0
Skip to Content
Cell Technologies
About
Our Technology
Pipeline
Investors
Contact
Cell Technologies
About
Our Technology
Pipeline
Investors
Contact
About
Our Technology
Pipeline
Investors
Contact